Many natural compounds with interesting biomedical properties share one physicochemical property, namely a low water solubility. Polymer micelles are, among others, a popular means to solubilize hydrophobic compounds. The specific molecular interactions between the polymers and the hydrophobic drugs are diverse and recently it has been discussed that macromolecular engineering can be used to optimize drug loaded micelles. Specifically, π-π stacking between small molecules and polymers has been discussed as an important interaction that can be employed to increase drug loading and formulation stability. Here, we test this hypothesis using four different polymer amphiphiles with varying aromatic content and various natural products that also contain different relative amounts of aromatic moieties. While in the case of paclitaxel, having the lowest relative content of aromatic moieties, the drug loading decreases with increasing relative aromatic amount in the polymer, the drug loading of curcumin, having a much higher relative aromatic content, is increased.
Introduction:
For many years, natural products have played an important part in drug discovery. In the late 20 th century, a majority of drugs were either natural compounds or their derivatives. [1] At the end of their review concerning the importance of natural products for drug discovery Newman et al. argued that well-defined drug delivery systems could overcome unfavorable physicochemical properties, like aqueous solubility, in the future. [2] Through high-throughput screening, new chemical entities or lead structures are being identified and evaluated every day, [3] but only a minute fraction ever ripen into an approved drug. Obviously, a large proportion of drug candidates are poorly water-soluble [4, 5] which calls for effective formulation strategies. Traditionally used surfactants like Cremophor EL and Tween 80 have drawbacks as they can elicit potentially life-threatening side effects and are limited with respect to their in solubilizing ability. [6, 7] Polymeric micelles have been discussed and evaluated as carriers for hydrophobic molecules for many years and thousands of papers praising the potential of polymer based drug delivery systems are published every year. [8] However, until now, only one micelle-based formulation (Genexol-PM®, South Korea) has been used in the clinic with several other being under clinical development. [9] Zhang et al.
argued that the low drug loading capacity and poor in vivo stability typically displayed by polymeric micelles is responsible for this major discrepancy. [10] These major problems concerning nanoformulations, drug delivery and the advancement of polymeric micelles for clinical cancer therapy were also critically reviewed by other researchers. [11] [12] [13] Polymer micelles comprising a poly(2-oxazoline) (POx) based amphiphilic triblock copolymer (poly(2-methyl-2-oxazoline)-block-poly(2-butyl-2-oxazoline)-block-poly(2-methyl-2-oxazoline) (PMeOx-b-PBuOx-b-PMeOx ≡ A-pBuOx-A)) constitute an unusual exception.
Loading capacities (LC) of almost 50 wt.% for one of the most commonly used chemotherapeutic agents, paclitaxel (PTX), [14] were reported by Kabanov, Jordan,
Luxenhofer and co-workers. [15] [16] [17] [18] [19] . Despite the very low water solubility, PTX is a high affinity substrate for P-glycoprotein (P-gp) which leads to PTX resistance in cancer cells. [20] [21] [22] The drug loaded polymer micelles formed stable and injectable formulations and showed significantly increased therapeutic efficacy.
[23] The combination of high drug loading and stability was only seen in block copolymers with poly(2-n-butyl-2-oxazoline) as hydrophobic core. [19] Testing a variety of structurally different taxanes led to similar high drug loadings and stability of the formulations.
[24] However, with etoposide and bortezomib, two wellknown topoisomerase and proteasome inhibitors, respectively, no stable formulations could be obtained. [15, 17] Lübtow et al. investigated a small library of structurally similar ABAtriblock copolymers based on poly(2-oxazoline)s and poly(2-oxazine)s and explored their solubilization capacity for PTX and curcumin (CUR [25] ), another well-known natural compound featuring extremely low aqueous solubility, bioavailability and stability.
[26] The authors observed significant and orthogonal specificities dependent on one methylene group.
That research outlines the complexity of drug/carrier interactions.
[27] More recently, this CUR nanoformulation was characterized in detail and compared in 2D and 3D cell culture with CUR dissolved in DMSO. [28] Another natural product with low water solubility can be found in fruits of Schisandra chinensis, which are widely used in traditional Chinese and Japanese herbal medicine and are said to have hepatoprotective, anti-asthmatic, anti-diabetic and sedative properties. [ containing poly(2-phenyl-2-oxazolin) (PPheOx) and PMeOx were tested on their self-assembly in aqueous milieu. Dependent on different block compositions, the researchers found polymeric micelles, vesicles and larger polymersomes. Furthermore, the hydrophobic drug indomethacin could be successfully formulated. [58] Tiller and co-workers described ABAtriblock copolymers based on PPheOx and PMeOx and discussed their usage in drug delivery.
The size and morphology of the aggregates depended strongly on the overall block length and the balance between hydrophilic and hydrophobic moieties.
[59] Here, we present a small library of POx based amphiphiles, in which the aromatic character was increased systematically and the solubilization capacity for drugs with different aromatic content was investigated.
Materials and Methods:
All substances and reagents for the polymerizations were obtained from Sigma-Aldrich and distilled and stored under argon. Benzonitrile (PhCN) was dried over phosphorus pentoxide. The monomers 2-n-butyl-2-oxazoline (BuOx) and 2-benzyl-2-oxazoline (BzOx) were synthesized following the well-known procedure by Seeliger et al. [60] The Pt-NHC-complex and melting points (mp) were determined by differential scanning calorimetry (DSC)
measurements. All methods are described in more detail in the supporting information.
Results and Discussion:
Inspired by reports on benefits for drug delivery via π-π stacking between drug carrier and loaded API [65] , we wanted to investigate this issue in poly(2-oxazoline) based polymer amphiphiles. In particular, the Hansen-solubility parameters calculated by Dargaville and coworkers suggested a benefit regarding drug loading using polymer amphiphiles comprising a hydrophobic poly(2-phenyl-2-oxazoline) block. [66] In the case of paclitaxel and docetaxel, Hennink and co-workers reported that incorporation of aromatic side chains into thermosensitive block copolymers of modified hydroxypropyl methacrylamides improves drug loading.
[56] However, it is important to note that in this study PTX precipitation rather than release was quantified. [56, 57] The authors argue that this was done as it is difficult to upload proper sink conditions for the extremely poorly soluble PTX.
In contrast, in a preliminary study, we did not observe any benefit with respect to PTX formulation when we included aromatic moieties into the hydrophobic block. Therefore, the present study investigates the influence of different proportions of aromatic moieties within poly(2-oxazoline) based ABA triblock copolymers on the formulation of different hydrophobic drugs with varying aromatic content in more detail. To this end, we used a small library of four different polymers. As in previous work, the hydrophilic block A was poly(2-methyl-2-oxazoline) (pMeOx).
[27] The hydrophobic blocks were in order of increasing aromatic content poly(2-butyl-2-oxazoline) (A-pBuOx-A), poly(2-butyl-2-oxazoline-
poly(2-phenyl-2-oxazoline) A-pPheOx-A, respectively. The polymers were prepared by living cationic ring opening polymerization (LCROP) and characterized by 1 H-NMR and GPC (Table 1 and supporting information). All polymers exhibited CMC values in the low μM range (determined by pyrene fluorescence, Figure S3 ), often deemed favorable for intravenous administration ( Figure S3 , Table S1 ).
Interestingly, in the present library, it appears that the introduction of aromatic side chains has no marked influence on the CMC values. For formulation, we focused on three natural compounds. On the one hand, we employed the well-known and extremely water-insoluble SchA contains two rings at 432 g/mol and CUR contains also 2 phenyl rings, however connected with a bridging π-system at a molar mass of 368 g/mol. The ratio of C arom. , the carbon atoms, which are included in the aromatic system, and C total , the total number of carbon atoms in the hydrophobic compound, represents the aromaticity of the three different cargos ( Table 2) . Additionally, the insoluble compounds Pt-NHC and CUR-F 6 (for structures, please see Figure   S6 ) were investigated, the latter of which can be viewed as derivative of natural compound CUR.
All four polymers were tested for the solubilization of PTX and CUR, while A-pPheOx-A was not used to formulate SchA. As previously reported, A-pBuOx-A is an excellent solubilizer for PTX but much less so for CUR.
[27] This was corroborated also in the present study ( Figure 2 ).
Interestingly, SchA, having an intermediate relative aromatic content was solubilized very well, but less than PTX. As previously reported [19] and independently reproduced here using a newly synthesized polymer, the introduction of benzylic moieties (A-p(BuOx-co-BzOx)-A)
does not help in the formulation of PTX but rather reduces the maximum drug loading.
Interestingly, while in the case of SchA the maximum drug loading increased slightly, the LC CUR that could be achieved increased significantly ( Figure 2 be noted that this comparably low loading of PTX using A-pPheOx-A was still higher, albeit only slightly, than the highest PTX loading reported by Hennink et al. [56] In this report, the authors found an increased PTX loading with increasing content of aromatic co-monomer, which was attributed to π-π stacking between polymer and drug molecules. While apparently valid in some cases, it appears that this rationale is not generally helpful to increase drug loading in polymer micelles. Due to insufficient amounts of SchA, this compound was not tested using A-pPheOx-A.
It should be noted that we also attempted formulation of CUR-F 6 , but no stable formulation could be obtained by film hydration method with either polymer. The NHC-Pt-complex was solubilized with A-pPheOx-A by film hydration method using dichloromethane. However, it appears the complex does not exhibit sufficient stability as HPLC analysis revealed multiple signals after formulation whereas the compound was pure initially. Therefore, quantification was not possible. . In all cases, the polymer concentration was fixed at 10 g/L. Data is given as means ± SD (n = 3).
The drug content was quantified immediately after preparation. In order to gain a basic understanding of the stability of the drug formulations, we stored the formulation under ambient conditions and took samples after 10 and 30 days. For A-pBuOx-A, we have previously observed excellent stability of the PTX formulation without any precipitation after several months. [15, 17, 18] In general, all tested formulations of PTX, CUR and SchA showed very good stability over 30 days (Figure 3) . No significant loss of SchA and very little variability of the drug concentration was observed. In the case of PTX, the variability was somewhat higher, nevertheless overall formulation stability was excellent. 
Conclusion:
We investigated the influence of incorporation of aromatic moieties into poly(2-oxazoline) based ABA triblock copolymers. In addition to the varying degree of aromaticity within the polymers, three cargo compounds with different relative aromatic content were tested. In contrast to previous reports on a different polymeric system, incorporation of 2-benzyl-2-oxazoline or 2-phenyl-2-oxazoline did not increase drug loading or formulation stability in the case of paclitaxel. Interestingly, the formulation of the natural compound schizandrin A was barely affected while the loading with curcumin benefitted significantly from incorporation of 2-benzyl-2-oxazoline but less so for 2-phenyl-2-oxazoline. Therefore, it appears that π-π stacking can be beneficial for drug loading and formulation stability in some cases, but this should not be considered a general phenomenon and must be assessed on a case-by-case basis.
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ABA-triblock copolymer synthesis according living cationic ring opening polymerization
General synthetic procedure 2, GSP 2
The used technique were carried out as described previously. [15] Briefly, 1 eq of initiator 
Extraction of schisandra chinensis fruits
The extraction procedure of fruits of schisandra chinensis was carried out as described by 
Infrared (IR) Spectroscopy
IR spectra were recorded on a FT-IR-spectrometer 4100 from 500 to 4000 cm -1 from Jasco (Gross-Umstadt, Germany). 
High Pressure Liquid Chromatography

Gel Permeation Chromatography (GPC)
Gel permeation chromatography (GPC) was performed either on a Polymer Standard Service 
Electrospray Ionization Mass Spectrometry (ESI-MS)
MS-Spectra were recorded on a micrOTOF-Q III spectrometer from Bruker Daltonic. 
Drug Solubilization
Drug loaded polymer micelles were prepared using the thin film method. 
Differential Scanning Calorimetry
The DSC measurements were performed in aluminum crucibles on a calibrated DSC 204 F1 Phoenix system from NETZSCH (Selb, Germany) equipped with a CC200 F1 controller unit. The heating and cooling rate was constantly 10 K/min using a constant N 2 -atmosphere. For each sample three heating cycles and two cooling cycles were performed. Glass transitions temperatures of ABA-triblock copolymers (binary system) ( ) ) are predictable using the well-known Fox equation [70] and the T g -values of the homopolymers ( ),I , ),S ) and the mass fractions ( I , S ), respectively (Equation 7; Table S10 ). pBzOx Not noted 61 [72] Structures of the hydrophobic drugs Pt-NHC and CUR-F 6 Figure S6 . Chemical structure of Pt-NHC [61] and CUR-F 6 [62] .
